Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulation

AAPS J. 2013 Jul;15(3):646-58. doi: 10.1208/s12248-013-9468-4. Epub 2013 Mar 30.

Abstract

Continuous improvement in bioanalytical method development is desired in order to ensure the quality of the data and to better support pharmacokinetic (PK) and safety studies of biotherapeutics. One area that has been getting increasing attention recently is in the assessment of "free" and "total" analyte and the impact of the assay format on those assessments. To compliment these considerations, the authors provide a critical review of available literature and prospectively explore methods to mitigate the potential impact of anti-drug antibody on PK assay measurement. This challenge is of particular interest and importance since biotherapeutic drugs often elicit an immune response, and thus may have a direct impact on quantification of the drug for its PK and safety evaluations.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies / blood*
  • Antibodies / therapeutic use
  • Biological Products / blood*
  • Biological Products / immunology
  • Biological Products / therapeutic use
  • Biological Therapy / methods*
  • Chemistry, Pharmaceutical / methods*
  • Humans

Substances

  • Antibodies
  • Biological Products